Heart Test Laboratories's receivables is $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (April 2026), HSCS shows a receivables of $0. That compares with $4.4K in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, HSCS's receivables is now $0 (was $4.4K) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Heart Test Laboratories is outperforming or lagging.
Tracking HSCS's receivables over time shows whether Heart Test Laboratories is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $4.4K in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Heart Test Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.